# Evaluation of the Efficacy and Safety of Two Methadone Titration Methods for the Treatment of Cancer-related Pain With Inadequate Pain Relief or Intolerable Side Effects When Treated With Level 3 Opioids.

> **NCT01793480** · PHASE3 · COMPLETED · sponsor: **RECORDATI GROUP** · enrollment: 146 (actual)

## Conditions studied

- Pain Related to Cancer

## Interventions

- **DRUG:** Methadone

## Key facts

- **NCT ID:** NCT01793480
- **Lead sponsor:** RECORDATI GROUP
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01-05
- **Primary completion:** 2014-05-06
- **Final completion:** 2014-08-31
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2024-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01793480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01793480, "Evaluation of the Efficacy and Safety of Two Methadone Titration Methods for the Treatment of Cancer-related Pain With Inadequate Pain Relief or Intolerable Side Effects When Treated With Level 3 Opioids.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01793480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*